Miriam Kidron
Chief Scientific Officer at Oramed Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Oramed Pharmaceuticals Inc., 3 years.
Oramed Pharmaceuticals Inc.
Director · Chief Scientific Officer
Lifeward Ltd.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Oramed Pharmaceuticals Inc. | Shares withheld for tax | −435,084 | $3.31 | $1,440,128 |
| Mar 25, 2026 | Lifeward Ltd. | Grant or award | +7,657 | — | — |
| Mar 17, 2026 | Oramed Pharmaceuticals Inc. | Grant or award | +119,558 | — | — |
| Jan 22, 2026 | Oramed Pharmaceuticals Inc. | Option exercise | +19,000 | — | — |
| Jan 14, 2026 | Oramed Pharmaceuticals Inc. | Gift | −86,166 | — | — |
| Dec 31, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +121,331 | — | — |
| Dec 31, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +115,000 | — | — |
| Feb 11, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +74,000 | — | — |
| Feb 11, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +52,000 | — | — |
| Feb 11, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +66,667 | — | — |
| Jan 2, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +207,000 | — | — |
| Nov 7, 2024 | Oramed Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
| Jan 4, 2024 | Oramed Pharmaceuticals Inc. | Grant or award | +295,500 | — | — |
| May 26, 2023 | Oramed Pharmaceuticals Inc. | Grant or award | +53,500 | — | — |
| Apr 17, 2023 | Oramed Pharmaceuticals Inc. | Grant or award | +213,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.